Intracranial Pressure - Nursing Case Study
Pathophysiology
• Primary mechanism: Increased intracranial volume due to mass effect (e.g., tumor, hematoma) leads to heightened intracranial pressure (ICP) by reducing available space within the skull, disrupting normal brain function and perfusion.
• Secondary mechanism: Disruption of cerebrospinal fluid (CSF) dynamics, either by overproduction, decreased absorption, or obstructed flow, exacerbates ICP by further decreasing intracranial compliance and impairing autoregulation.
• Key complication: Sustained elevated ICP results in cerebral herniation, where brain tissue is forced across structures within the skull, potentially causing brainstem compression, loss of vital autonomic functions, and rapid neurological deterioration.
Patient Profile
Demographics:
52-year-old male, construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Kidney Disease Stage 3
• Current medications: Lisinopril, Metformin, Amlodipine, Insulin glargine
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe headache and altered mental status
• Key symptoms: Nausea, vomiting, blurred vision, confusion, difficulty speaking
• Vital signs: Blood Pressure 190/110 mmHg, Heart Rate 45 bpm, Respiratory Rate 30 breaths per minute, Temperature 100.4°F, Oxygen Saturation 88% on room air
Section 1
Change in Patient Status:
As the clinical team continued to monitor the patient, there was a sudden and marked decline in his neurological status. The patient became unresponsive to verbal stimuli and was only responding to painful stimuli with decerebrate posturing, indicating a potential progression of brainstem involvement due to increased intracranial pressure. His pupils were noted to be unequal, with the left pupil fixed and dilated, suggesting transtentorial herniation. The patient's respiratory pattern shifted to Cheyne-Stokes breathing, and oxygen saturation dropped further to 82% despite supplemental oxygen via a non-rebreather mask.
A repeat CT scan of the head was urgently performed, revealing a substantial midline shift of 10 mm and evidence of uncal herniation. There was an increase in the size of the right-sided subdural hematoma, which had not been previously identified, indicating a new hemorrhagic event possibly exacerbated by the patient's uncontrolled hypertension. The patient's blood glucose was critically elevated at 450 mg/dL, complicating the metabolic demands on the already compromised brain tissue.
This sudden deterioration prompted the immediate initiation of advanced interventions. The neurosurgical team was consulted for possible surgical decompression, while the intensive care team prepared for potential invasive ICP monitoring and hyperosmolar therapy using mannitol or hypertonic saline to reduce cerebral edema. The patient's complex condition required the healthcare team to employ rapid clinical judgment to prioritize and sequence interventions, balancing the need to lower ICP with the management of the patient's underlying chronic conditions.
Section 2
Response to Interventions:
Following the immediate interventions, the patient's condition remained precarious. The administration of mannitol led to a modest reduction in intracranial pressure, as noted by a slight improvement in the patient's posturing from decerebrate to decorticate, indicating some relief in brainstem compression. However, his respiratory pattern continued to be erratic, with Cheyne-Stokes breathing persisting and intermittent episodes of apnea noted, necessitating intubation and mechanical ventilation to ensure adequate oxygenation. Despite these measures, the patient's oxygen saturation remained marginal, hovering around 88-90% with careful ventilation settings.
The neurosurgical team determined that surgical intervention was imperative. An emergent craniotomy was performed to evacuate the enlarging subdural hematoma and address the midline shift. During surgery, the team encountered significant cerebral edema and signs of ischemic damage to the right hemisphere, which complicated the procedure. Postoperatively, the patient's ICP showed a temporary decrease; however, it remained elevated at 25 mmHg, requiring continued hyperosmolar therapy.
In the intensive care unit, the patient's hemodynamics exhibited instability. Blood pressure fluctuated significantly despite aggressive management, with systolic readings ranging from 160 to 220 mmHg. The elevated blood glucose persisted at 420 mg/dL, necessitating an insulin infusion to avoid further metabolic derangement. The healthcare team was now faced with a multifaceted challenge: stabilizing the patient's cardiovascular status while maintaining cerebral perfusion and preventing secondary brain injury. This complex scenario required continuous monitoring and frequent adjustments to therapeutic strategies, underscoring the critical need for advanced clinical reasoning and interdisciplinary collaboration.
Section 3
New Complications:
As the team continued to manage the patient's complex condition, a new complication emerged. Approximately 24 hours postoperatively, the patient began exhibiting signs of syndrome of inappropriate antidiuretic hormone secretion (SIADH). Laboratory results showed a serum sodium level of 125 mmol/L, down from 138 mmol/L the previous day, indicating significant hyponatremia. Concurrently, the patient’s urine output decreased markedly, and urine osmolality was elevated at 650 mOsm/kg, suggestive of excessive secretion of antidiuretic hormone. This electrolyte imbalance further exacerbated cerebral edema, complicating intracranial pressure management.
The critical care team swiftly initiated a fluid restriction protocol and administered hypertonic saline to address the hyponatremia. Despite these interventions, the patient's neurological status deteriorated. He became unresponsive to painful stimuli, and pupil reactivity was sluggish, with a left fixed and dilated pupil noted upon examination. This alarming neurological decline prompted an immediate repeat CT scan, which revealed an increase in cerebral edema and a slight reherniation at the craniotomy site, indicating worsening brain swelling and necessitating urgent reevaluation of the treatment strategy.
In response, the team considered additional interventions such as the administration of a loop diuretic to manage fluid overload and further escalated hyperosmolar therapy. The patient's volatile status underscored the complexity of managing coexisting complications of traumatic brain injury, necessitating careful titration of therapies to balance the competing priorities of maintaining adequate cerebral perfusion pressure while preventing further neuronal injury. The interdisciplinary team remained vigilant, continuously reassessing and adjusting the treatment plan based on the patient's evolving clinical picture.
Section 4
Change in Patient Status
Despite the aggressive management of the patient's hyponatremia and cerebral edema, the patient's condition continued to deteriorate. Approximately 12 hours after the initiation of hypertonic saline and loop diuretics, the patient's vital signs became increasingly unstable. Blood pressure fluctuated dramatically, registering as low as 85/50 mmHg and as high as 160/100 mmHg within hours, reflecting severe autonomic dysregulation. Heart rate was noted to be tachycardic, ranging between 110-130 beats per minute, and the patient developed a fever of 39.5°C (103.1°F), suggesting the possibility of an infectious process or central fever secondary to brain injury.
Neurologically, the patient's Glasgow Coma Scale (GCS) score plummeted to 5, indicating severe impairment. Repeat neurological assessments revealed bilateral fixed and dilated pupils, suggesting significant brainstem involvement and possible impending brain death. The team recognized that these signs were ominous and indicative of increased intracranial pressure surpassing compensatory mechanisms, likely related to the expanding cerebral edema and potential progression of herniation.
In light of these alarming developments, the critical care team convened a multidisciplinary meeting to revisit the treatment plan. A decision was made to initiate barbiturate coma therapy in an attempt to reduce metabolic demand and cerebral blood flow, thereby controlling intracranial pressure. Additionally, broad-spectrum antibiotics were started empirically to address the potential for infection, and the patient was placed on continuous EEG monitoring to assess for non-convulsive seizures, which could further complicate the clinical picture. This complex interplay of interventions highlighted the necessity for advanced critical thinking and precise clinical judgment, as each decision carried significant risks and benefits in the context of preserving neurological function while combating life-threatening complications.
Section 5
Response to Interventions
Following the initiation of barbiturate coma therapy, there was a transient stabilization in the patient's vital signs, with blood pressure stabilizing around 110/70 mmHg and heart rate decreasing to 90 beats per minute. However, this reprieve was short-lived. Within six hours, the continuous EEG monitoring revealed frequent bursts of high-amplitude slow-wave activity interspersed with periods of electrical silence, indicating burst suppression. Despite this, the patient began exhibiting subtle myoclonic jerks of the extremities, raising concerns about ongoing subclinical seizure activity, which could exacerbate the already critical intracranial pressure.
Laboratory results painted a grim picture; arterial blood gases showed a developing metabolic acidosis with a pH of 7.28, HCO3 of 15 mEq/L, and a compensatory respiratory alkalosis with a pCO2 of 30 mmHg, suggesting worsening tissue perfusion and oxygenation. Serum sodium levels had improved to 134 mEq/L, but the improvement was overshadowed by a rising serum lactate level of 5.6 mmol/L, indicative of increased anaerobic metabolism and potential shock. These findings prompted the critical care team to reassess the adequacy of current interventions and consider potential adjustments in the ventilatory strategy and circulatory support.
As the situation evolved, the patient developed a new complication: acute kidney injury, evidenced by a sharp rise in serum creatinine from 1.1 mg/dL to 2.5 mg/dL and a decrease in urine output to less than 0.3 mL/kg/hr over the past four hours. This renal deterioration further complicated fluid management, challenging the team to balance the need for adequate perfusion and pressure control without exacerbating cerebral edema. The multidisciplinary team faced a daunting task in refining their approach, weighing the benefits and risks of escalating renal support with continuous renal replacement therapy while considering the delicate equilibrium required in managing the patient's rapidly fluctuating systemic and cerebral hemodynamics.